Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT.
Swoboda R, Labopin M, Giebel S, Angelucci E, Arat M, Aljurf M, Sica S, Pavlu J, Socié G, Bernasconi P, Rigacci L, Tischer J, Risitano A, Rovira M, Saccardi R, Pioltelli P, Van Gorkom G, Vitek A, Savani BN, Spyridonidis A, Peric Z, Nagler A, Mohty M. Swoboda R, et al. Bone Marrow Transplant. 2022 Mar;57(3):399-406. doi: 10.1038/s41409-021-01550-0. Epub 2022 Jan 15. Bone Marrow Transplant. 2022. PMID: 35031709
High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma.
Swoboda R, Giebel S, Knopińska-Posłuszny W, Chmielowska E, Drozd-Sokołowska J, Paszkiewicz-Kozik E, Kulikowski W, Taszner M, Mendrek W, Najda J, Czerw T, Olszewska-Szopa M, Czyż A, Giza A, Spychałowicz W, Subocz E, Szwedyk P, Krzywon A, Wilk A, Zaucha JM. Swoboda R, et al. Ann Hematol. 2021 Jul;100(7):1755-1767. doi: 10.1007/s00277-021-04448-5. Epub 2021 Feb 24. Ann Hematol. 2021. PMID: 33625572 Free PMC article.
Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A, Labopin M, Swoboda R, Pioltelli P, Arat M, Yakoub-Agha I, Kulagin A, Maria Raiola A, Ozdogu H, Risitano A, Nur Ozkurt Z, Sanz J, Brissot E, Zina P, Giebel S, Ciceri F, Mohty M. Nagler A, et al. Among authors: swoboda r. Hemasphere. 2022 Oct 13;6(11):e790. doi: 10.1097/HS9.0000000000000790. eCollection 2022 Nov. Hemasphere. 2022. PMID: 36258924 Free PMC article.
Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMT.
Swoboda R, Labopin M, Giebel S, Schroeder T, Kröger N, Arat M, Savani B, Spyridonidis A, Hamladji RM, Potter V, Berceanu A, Yakoub-Agha I, Rambaldi A, Ozdogu H, Sanz J, Nagler A, Mohty M. Swoboda R, et al. Bone Marrow Transplant. 2023 Mar;58(3):282-287. doi: 10.1038/s41409-022-01882-5. Epub 2022 Dec 2. Bone Marrow Transplant. 2023. PMID: 36460819
Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S, Labopin M, Schroeder T, Swoboda R, Maertens J, Bourhis JH, Grillo G, Salmenniemi U, Hilgendorf I, Kröger N, Poiré X, Cornelissen JJ, Arat M, Savani B, Spyridonidis A, Nagler A, Mohty M. Giebel S, et al. Among authors: swoboda r. Am J Hematol. 2023 Apr;98(4):580-587. doi: 10.1002/ajh.26825. Epub 2023 Jan 10. Am J Hematol. 2023. PMID: 36626592 Free article.
Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A, Labopin M, Swoboda R, Kulagin A, Labussière-Wallet H, Rovira M, Blaise D, Vydra J, Yakoub-Agha I, Choi G, Reményi P, Koc Y, Sanz J, Ciceri F, Mohty M. Nagler A, et al. Among authors: swoboda r. Bone Marrow Transplant. 2023 May;58(5):552-557. doi: 10.1038/s41409-023-01940-6. Epub 2023 Feb 23. Bone Marrow Transplant. 2023. PMID: 36823454
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A, Labopin M, Swoboda R, Kulagin A, Velardi A, Sanz J, Labussière-Wallet H, Potter V, Kuball J, Sica S, Parovichnikova E, Bethge W, Maillard N, Platzbecker U, Stölzel F, Ciceri F, Mohty M. Nagler A, et al. Among authors: swoboda r. Bone Marrow Transplant. 2023 Sep;58(9):1008-1016. doi: 10.1038/s41409-023-02012-5. Epub 2023 May 30. Bone Marrow Transplant. 2023. PMID: 37253804
101 results